Navigation Links
Esphera3 International Founded on 'Patient Focused Care'
Date:2/19/2009

KALAMAZOO, Mich., Feb. 19 /PRNewswire/ -- Esphera3 International (E3I) is a broad based Integrated Healthcare Group founded on the principles of "Patient Focused Care." Currently engaged in multiple projects around the world, E3I encompasses all aspects of a partnered care health approach including operational transformation to optimize the design, resource management and financial operations of healthcare.

E3I and its channel partners enjoy a combined total of a 25-year relationship with Stryker Corporation along with 25 years experience planning, building, and developing healthcare facilities and maximizing operations. E3I has emerged as a global development business with the strength of its channel partners in banking, investment, real estate, management operations, and training.

According to Tom Fullan, a consultant to E3I and the Stryker Corporation, "Partnered Care Health, Operational Optimization and MySim2Learn are the focus areas that demonstrate an enduring legacy in assisting doctors, nurses, and allied health workers in the quest to raise the quality bar in healthcare. E3I has been developed to work collaboratively with Stryker Corporate Clients worldwide and to focus on quality delivery and patient safety."

Esphera3 International launched an expanded, redesigned website on February 19, 2009 at www.esphera3i.com. There you will find the broad base of capabilities comprised of Education, Operations Optimization and Infrastructure.

For more information on E3I contact Tom Fullan, (877) 269-0788 or visit www.esphera3i.com.

About E3I

Esphera3 International (E3I) is an entity that balances healthcare facility design, construction, and development owned by M.W. Vander Veen Company (development), Eckert Wordell (medical planning, design and equipment), and CSM Group (construction) all from Kalamazoo, Michigan.

E3I enjoys a cumulative 25-year relationship with Stryker Corporation and also 25 years of experience planning, building, and developing healthcare facilities in the United States and Canada. For more information on E3I, visit www.esphera3i.com .

About Stryker

Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopedics and a significant presence in other medical specialties. Stryker works with respected medical professionals to help people lead more active and more satisfying lives and to reduce healthcare costs. The company's products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. For more information on Stryker, visit www.stryker.com.


'/>"/>
SOURCE Esphera3 International
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Valensa Internationals Dr. Rudi E. Moerck Appointed CEO
2. Osteotech Receives 13485:2003 ISO Certification; Company Meets International Standards for Medical Device Manufacturing
3. IOF joins ECCEO9 at leading international meeting in Athens
4. The Canadian Foundation for Global Health Announces a Research and Development Partnership with Medizone International, Inc.
5. HUYA Bioscience International Announces Collaboration Agreement With the Beijing Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College
6. China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results
7. International Humanization of Birth Conference
8. Natural Alternatives International, Inc. Announces Fiscal 2009 Q2 Results
9. WaterHealth International Announces $15 Million Financing by IFC
10. i.HUG Foundation Receives International Grant: Hires a School Nurse to Improve Student Health and Learning
11. Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million;
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... , ... April 24, 2017 , ... ... designed to recognize elevated anxiety levels in people with addiction who are served ... Smart Patch, a biosensing wearable device that monitors heart and breath rates to ...
(Date:4/24/2017)... ... April 24, 2017 , ... Labs often perform the ... for lab operators and management to assess these processes with a critical eye—particularly ... unnecessary actions. , Created with the help of both internal and external ...
(Date:4/24/2017)... ... ... “The Saint with Trin, and Omega Station”: a triple feature offering nonstop action ... author, Chris Jackson. Chris Jackson grew up in Abilene, Texas. He now ... teaching English. He is heavily involved in the youth group of his local church. ...
(Date:4/24/2017)... ... , ... A 2-in-1 bottleless water appliance provides both purified ... Texas, here are the ways in which this technology can benefit dental offices: ... fresh, oxygenated water, with both cold and hot options. , Convenience for Dentists ...
(Date:4/22/2017)... NY (PRWEB) , ... April 22, 2017 , ... ... which shows that U.S. consumers can save an average of 70% when buying ... savings (up to 97%) are available when purchasing from other countries. The report ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... positive preclinical results demonstrating anti-fibrotic effects with ... steatohepatitis (NASH), in an additional well-validated experimental ... has previously shown similar anti-fibrotic effects in ... scientists present novel data demonstrating anti-fibrotic effects ...
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... release financial results for the first quarter 2017 after ... The Company,s management team will host a corresponding conference ... ET. Investors interested in listening to the ... for domestic callers or (703) 326-3030 for international callers, ...
(Date:4/19/2017)... SAN DIEGO , April 19, 2017 /PRNewswire/ ... ("Sorrento"), an antibody-centric, clinical-stage biopharmaceutical company developing new ... today announced the closing of its previously announced ... common stock at a public offering price of ... commissions and estimated offering expenses payable by Sorrento.  ...
Breaking Medicine Technology: